Empowered Funds
HUMA icon

Empowered Funds’s Humacyte HUMA Stock Holding History

Empowered Funds’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$81.5K Buy
+157,378
New +$101K ﹤0.01% 2435

Other funds holding HUMA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.43B AUM 15.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Endowment Wealth Management
Endowment Wealth Management Appleton, Wisconsin $292M AUM 11.49% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Empowered Funds's HUMA Position: Q3 2026 in Review

Empowered Funds opened a new position in Humacyte (HUMA) in Q3 2026: 157,378 shares worth $81.5K. The stake represents ﹤0.01% of the portfolio and ranks #2435 among its holdings.

98 funds tracked by Wall St. Rank hold HUMA as of Q3 2026.

  • Empowered Funds held 157,378 shares of Humacyte worth $81.5K as of Q3 2026.
  • Humacyte was a new Empowered Funds position in Q3 2026.
  • Humacyte made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2435 holding.
  • 98 funds tracked by Wall St. Rank held Humacyte as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.